A Missouri appellate court has upheld a $495 million verdict against Abbott Laboratories in a case over whether its formula ...

The S&P 500 Health Care sector ($SRHC) has been one of the weakest spots in the market in 2026, and Abbott Laboratories (ABT) ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

CHICAGO, April 10 (Reuters) - A jury in Chicago on Friday said Abbott Laboratories (ABT.N), opens new tab must pay $70 million in damages to a group of families that had accused the company of failing ...

It essentially met analyst expectations for its inaugural quarter of 2026.

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 ...

A Cook County jury found the Lake County company's cow-milk-based infant formula contributed to a life-threatening condition in premature infants.

Track key insider buying and selling across ABT, SPGI, IP, CHTR, UNH, NOW and HAL—see who’s buying near lows, selling, and what it signals.

Abbott Laboratories must pay $53 million in compensatory damages in four cases in which Chicago area babies developed a ...

View Abbott Laboratories ABT stock quote prices, financial information, real-time forecasts, and company news from CNN.

Abbott Laboratories (ABT) is back in focus after presenting new multi-biomarker data for its Cancerguard multi cancer early ...

Whether Abbott Laboratories (NYSE: ABT) stock is at a good entry point depends on your investment horizon and tolerance for ...